Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effects.

Molecular cancer research : MCR - 1 Oct 2012

Jing Yuqi, Kovacs Krisztina, Kurisetty Vittal, Jiang Zhijie, Tsinoremas Nick, Merchan Jaime R

Abstract excerpt

Tumor proteases and inhibitors have been associated with paradoxical effects on tumor progression in preclinical and clinical settings. We previously reported that urokinase (uPA) overexpression delays tumor progression in mammary cancer. This study aimed to determine the role of plasminogen activator inhibitor-1 (PAI-1) on uPA's paradoxical in vivo effects. Using syngeneic murine models, we found that stable uPA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clone Cells
Share to Disease Progression

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Down-Regulation

Share to Mice, Inbred BALB C

Share to Neoplasm Metastasis

Share to Oligonucleotide Array Sequence Analysis

Share to Plasminogen Activator Inhibitor 1

Share to Urokinase-Type Plasminogen Activator

Source

Open in PubMed Open full text

Identifiers

PMID: 22912336
DOI: 10.1158/1541-7786.MCR-12-0145
PMCID: PMC3495620

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effects.PMID 22912336Read ↗

The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding.Semantic proximity Read ↗

Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.Semantic proximity Read ↗

Diversity and functional evolution of the plasminogen activator system.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasisSemantic proximity Read ↗

The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive RoleSemantic proximity Read ↗

Investigating the Role of Urokinase in Cancer Metastasis: A ReviewSemantic proximity Read ↗

Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumorsSemantic proximity Read ↗

Cancer invasion and tissue remodeling‐cooperation of protease systems and cell typesSemantic proximity Read ↗

Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.Semantic proximity Read ↗

Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice.Semantic proximity Read ↗

Transforming Growth Factor-Beta and Urokinase-Type Plasminogen Activator: Dangerous Partners in Tumorigenesis—Implications in Skin CancerSemantic proximity Read ↗

Cancer invasion and metastasis: changing viewsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.